GI
DNA icon

GAMMA Investing’s Ginkgo Bioworks DNA Stock Holding History

GAMMA Investing’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.2K Buy
1,338
+300
+29% +$2.44K ﹤0.01% 3040
2026
Q2 		$10.3K Buy
1,038
+203
+24% +$1.7K ﹤0.01% 3192
2026
Q1 		$5.12K Buy
835
+312
+60% +$2.6K ﹤0.01% 3352
2025
Q4 		$4.35K Buy
523
+435
+494% +$4.68K ﹤0.01% 3346
2025
Q3 		$1.28K Buy
+88
New +$1.05K ﹤0.01% 3555
2025
Q1 		– Sell
-78
Closed -$766 – 3818
2024
Q4 		$766 Buy
78
+22
+39% +$189 ﹤0.01% 3489
2024
Q3 		$456 Buy
+56
New +$561 ﹤0.01% 3407
2024
Q2 		– Sell
-59
Closed -$2.76K – 3473
2024
Q1 		$2.76K Sell
59
-92
-61% -$4.76K ﹤0.01% 2642
2023
Q4 		$7.3K Buy
+151
New +$9.25K ﹤0.01% 2060

Other funds holding DNA

QFMHK
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

GAMMA Investing's DNA Position: Q3 2026 in Review

GAMMA Investing increased its Ginkgo Bioworks (DNA) stake by 29% in Q3 2026, buying an estimated $2.44K and bringing the position to 1,338 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

GAMMA Investing first reported a position in DNA in Q4 2023 and has held it in 9 quarters since. 9 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • GAMMA Investing held 1,338 shares of Ginkgo Bioworks worth $17.2K as of Q3 2026.
  • GAMMA Investing bought 300 Ginkgo Bioworks shares in Q3 2026, an estimated $2.44K.
  • Ginkgo Bioworks made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3040 holding.
  • GAMMA Investing first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 9 quarters since.
  • 9 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.